News Announcement

Piramal Pharma: Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Receipt Of Establishment Inspection Report ('EIR') With Respect To US FDA Inspection At Piramal Pharma'S Manufacturing Facility Located At Ahmedabad India

In furtherance to our letter dated 12th July 2024 this is to inform you that US FDA has issued an EIR for the Piramal Pharma s manufacturing facility located at Ahmedabad.


दूसरी कैटेगरी